metastatic/adv melanoma (mML) | |
mML - L2 - all population | |
pembrolizumab (10mg/kg) | KEYNOTE-006 ... KEYNOTE-002 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -